Robust dimensions of anxiety sensitivity: Development and initial validation of the Anxiety Sensitivity Index-3.

Taylor, Steven; Zvolensky, Michael J.; Cox, Brian J.; Deacon, Brett J.; Heimberg, Richard G.; Ledley, Deborah Roth; Abramowitz, Jonathan S.; Holaway, Robert M.; Sandín, Bonifacio; Stewart, Sherry H.; Coles, Meredith E.; Eng, Winnie; Daly, Erin S.; Arrindell, Willem A.; Bouvard, Martine; Cárdenas, Samuel Jurado

doi:10.1037/1040-3590.19.2.176

Cited by 1,474 publications

(1,522 citation statements)

References 30 publications

Supporting

Mentioning

1,431

Contrasting

Unclassified

Order By: Relevance

“…The ASI-3 was developed by Taylor et al in order to evaluate a tendency to experience health-related anxiety sensitivity (Taylor et al, 2007). The ASI-3 consisting of three subscales (physical, cognitive and social) and a total of 18 items were also tested for validity and reliability in our country (Mantar, Yemez, & Alkin, 2010).…”

Section: Anxiety Sensitivity Inventory-3 (Asi-3)mentioning

confidence: 99%

The Cyberchondria Severity Scale (CSS): Validity and Reliability Study of the Turkish Version

Selvı¹,

Turan²,

Sayin³

et al. 2018

Sleep Hypn

View full text Add to dashboard Cite

Objective: Even though the internet is a valuable resource for medical information, it has the potential to increase anxiety, fear or obsessive-compulsive behaviours, particularly among individuals more prone to health related anxiety. Researchers have found that health anxiety, hypochondria, and online health searches are associated with increased anxious symptomatology. The aim of this study is to investigate the psychometric properties of the Turkish version of the Cyberchondria Severity Scale, a measure of online health anxiety. Method: Three hundred thirty-seven university students with an age range of 16-55 were included in the study. The Cyberchondria Severity Scale (CSS), Internet Addiction Test (IAT), Anxiety Sensitivity Inventory-3 (ASI-3), and Health Anxiety Inventory (HAI) were administered to participants. Results: Confirmatory factor analysis revealed that five-factor solution best fit to the data. The overall and subscales of the CSS had excellent internal consistency (Cronbach α = 0.91, for the overall measure, and Cronbach α values ranged from 0.78 to 0.87), with an exception of 'mistruct of medical professional' subscale (Cronbach α = 0.64). The total and subscales of the CSS had generally good convergent validity. Conclusion: The CSS is a newly developed screening tool to assess online health anxiety, and present study demonstrated that the Turkish version of the scale had promising psychometric properties.

show abstract

Section: Anxiety Sensitivity Inventory-3 (Asi-3)mentioning

confidence: 99%

The Cyberchondria Severity Scale (CSS): Validity and Reliability Study of the Turkish Version

Selvı¹,

Turan²,

Sayin³

et al. 2018

Sleep Hypn

View full text Add to dashboard Cite

show abstract

“…Tal como se destaca en el DSM-5 (APA, 2014) los ataques de pánico pueden ocurrir en cualquier trastorno de ansiedad (p. 214). El paciente reportó alta SA de acuerdo al Índice de Sensibilidad Ansiosa (ASI-3) con un puntaje global, en rango clínico, de 34 (Taylor et al, 2007). En intentos anteriores de cesación tabá-quica, refirió haber tomado benzodiacepinas para su ansiedad así como también Bupropion y parches de nicotina.…”

Section: Perfil Del Participanteunclassified

“…Índice de Sensibilidad Ansiosa (ASI-3; Taylor, et al, 2007): Evalúa el nivel de SA del individuo. Consta de 18 ítems (por ej., "me asusto cuando mi corazón late rápidamente") que pueden ser puntuados en una escala likert de 5 puntos.…”

Section: Instrumentos De Evaluación Información Generalunclassified

“…Consta de 18 ítems (por ej., "me asusto cuando mi corazón late rápidamente") que pueden ser puntuados en una escala likert de 5 puntos. Sus propiedades psicométricas son adecuadas (Taylor, et al, 2007) y han sido documentadas en fumadores (Farris, DiBello, Allan, Schmidt y Zvolensky, en prensa). La suma de los puntajes son calculados para cada sub-factor (físico, cognitivo, y preocupaciones sociales) separados y/o juntos para un puntaje global de SA.…”

Section: Instrumentos De Evaluación Información Generalunclassified

“…Hubo cambios significativos en el nivel de SA del paciente al llegar el día de abandono (Ver Figura 3). Al entrar en el período de abstinencia, los niveles de SA eran consistentes con aquellos reportados por muestras no-clínicas, e inferiores a los reportados por personas con un diagnóstico de TAG (valor de referencia ≤27,5) (Taylor, et al, 2007). Hacia la semana 7-9 se puede observar un repunte en los niveles de SA que coinciden con el período en el cual el paciente atravesó por situaciones de estrés laboral, a pesar de ello, la SA no regresó a los niveles originales, y el paciente no volvió a fumar.…”

Section: Sensibilidad Ansiosaunclassified

See 2 more Smart Citations

Smoking Cessation Treatment, Anxiety Sensitivity Reduction and Emotional Regulation Coping: A Case Study

2017

RACP

View full text Add to dashboard Cite

show abstract

Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease

et al. 2021

View full text Add to dashboard Cite

IMPORTANCE Anxiety is common among patients with coronary heart disease (CHD) and is associated with worse health outcomes; however, effective treatment for anxiety in patients with CHD is uncertain.OBJECTIVE To determine whether exercise and escitalopram are better than placebo in reducing symptoms of anxiety as measured by the Hospital Anxiety and Depression-Anxiety Subscale (HADS-A) and in improving CHD risk biomarkers. DESIGN, SETTING, AND PARTICIPANTSThis randomized clinical trial was conducted between January 2016 and May 2020 in a tertiary care teaching hospital in the US and included 128 outpatients with stable CHD and a diagnosed anxiety disorder or a HADS-A score of 8 or higher who were older than 40 years, sedentary, and not currently receiving mental health treatment.INTERVENTIONS Twelve weeks of aerobic exercise 3 times per week at an intensity of 70% to 85% heart rate reserve, escitalopram (up to 20 mg per day), or placebo pill equivalent. MAIN OUTCOMES AND MEASURESThe primary outcome was HADS-A score. CHD biomarkers included heart rate variability, baroreflex sensitivity, and flow-mediated dilation, along with 24-hour urinary catecholamines. RESULTSThe study included 128 participants. The mean (SD) age was 64.6 (9.6) years, and 37 participants (29%) were women. Participants randomized to the exercise group and escitalopram group reported greater reductions in HADS-A (exercise, −4.0; 95% CI, −4.7 to −3.2; escitalopram, −5.7; 95% CI, −6.4 to −5.0) compared with those randomized to placebo (−3.5; 95% CI, −4.5 to −2.4; P = .03); participants randomized to escitalopram reported less anxiety compared with those randomized to exercise (−1.67; 95% CI, −2.68 to −0.66; P = .002). Significant postintervention group differences in 24-hour urinary catecholamines were found (exercise z score = 0.05; 95% CI, −0.2 to 0.3; escitalopram z score = −0.24; 95% CI, −0.4 to 0; placebo z score = 0.36; 95% CI, 0 to 0.7), with greater reductions in the exercise group and escitalopram group compared with the placebo group (F 1,127 = 4.93; P = .01) and greater reductions in the escitalopram group compared with the exercise group (F 1,127 = 4.37; P = .04). All groups achieved comparable but small changes in CHD biomarkers, with no differences between treatment groups.CONCLUSIONS AND RELEVANCE Treatment of anxiety with escitalopram was safe and effective for reducing anxiety in patients with CHD. However, the beneficial effects of exercise on anxiety symptoms were less consistent. Exercise and escitalopram did not improve CHD biomarkers of risk, which should prompt further investigation of these interventions on clinical outcomes in patients with anxiety and CHD.

show abstract

Robust dimensions of anxiety sensitivity: Development and initial validation of the Anxiety Sensitivity Index-3.

Cited by 1,474 publications

References 30 publications

The Cyberchondria Severity Scale (CSS): Validity and Reliability Study of the Turkish Version

The Cyberchondria Severity Scale (CSS): Validity and Reliability Study of the Turkish Version

Smoking Cessation Treatment, Anxiety Sensitivity Reduction and Emotional Regulation Coping: A Case Study

Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease

Contact Info

Product

Resources

About